Front page » News » Validated in the Nordics, needed across Europe: an investment perspective on Nordic healthcare expansion

Blogs

Validated in the Nordics, needed across Europe: an investment perspective on Nordic healthcare expansion

The same demographic and fiscal pressures now intensifying across continental European healthcare have shaped the Nordic operating environment for some time. A cohort of Nordic healthcare companies has validated solutions to problems EU5 systems are only now confronting — and PE investors are taking note.

EU5 healthcare markets face a tightening equation: care demand is accelerating, clinical capacity is contracting, and fiscal headroom is at a generational low. The viable response is healthcare productivity — care-delivery and digital-health models whose unit economics, scalability, and clinical outcomes have been proven in production. Such proven evidence is scarce inside EU5 today; it exists in growing volume in the Nordics. For example population aged over 80 years growth rate has been 3,4% in the Nordics already.

EU5 over-80 population growth
~1.8% per year, accelerating to 2.6% in 2030s

Doctors aged 55+ in Italy 44%
35% in France, 32% in Germany

Nordic 80+ growth rate 3.4%
per year 2020–25, nearly 2× EU5 rate

Demographic, workforce, and fiscal pressures on EU5 healthcare are intensifying now

The over-80 population in EU5 is growing at approximately 1.8% per year and accelerates to 2.6% through the 2030s — an additional 12+ million high-acuity citizens by 2045. The clinical workforce serving them is ageing on the same curve. Retirement is concentrated precisely where care demand is rising fastest.

Fiscal capacity to absorb this pressure has narrowed in parallel. France runs a deficit of 5.8% of GDP; every other EU5 economy sits at or above the 3% Maastricht reference. Per-capita health spend has nonetheless grown 2.8–5.1% per year over the past decade — the cost trajectory is structural, not cyclical. Where rising care demand and rising delivery cost meet a thinning funding base, healthcare productivity gains move from strategic preference to operational necessity.

The Nordic operating environment has enabled new healthcare productivity solutions to validate at scale

Nordic health systems have faced similar structural pressures earlier than EU5 peers. Three structural features of the Nordic operating environment have made the local market unusually permissive of new healthcare-delivery entrants:

  • Public organisation and cost responsibility in care delivery have created well-defined institutional buyers with recurring incentives to procure productivity-improving solutions.
  • Sustained investment in shared digital infrastructure — national eID, unified patient registries, interoperability standards — has let new digital health solutions integrate, scale, and generate real-world evidence without rebuilding the plumbing.
  • Adaptive regulatory and reimbursement frameworks have been progressively updated to admit new providers and digital products into reimbursed care.

The result is a body of healthcare solutions whose adoption mechanics are empirically known: telemedicine scaled into millions of reimbursed consultations; automated home-care medication dispensing operating at regional scale; mobile clinical workflow software in production at scores of hospitals. Implementation friction, payer sensitivities, and unit-economics behaviour at scale are no longer hypothetical. They have been encountered, addressed, and operationalised.

Similar conditions have emerged across EU5 — and Nordic operators are already meeting that demand

The structural enablers that shaped Nordic adoption are now appearing across EU5. Reimbursement pathways for digital health are being formalised, Germany’s DiGA and France’s PECAN are the leading examples, removing one of the classic market-entry risks.

Post-pandemic public investment programmes have created an unprecedented order book for digital and productivity-improving healthcare solutions:

Germany
KHZG
€4.3bn

United Kingdom
NHS technology allocation
up to £10bn

France
France 2030 digital health pillar
€7.5bn

Italy
PNRR Mission 6
€15.6bn

The European Health Data Space (EHDS), in force since March 2025, is further accelerating this dynamic. By mandating a common EU framework for health data exchange and EHR interoperability, it is turning Nordic digital infrastructure, built on national registries, unique identifiers, and interoperability standards, from a regional advantage into a continental one. For investors and Nordic platforms alike, the EHDS timeline sharpens an already compelling right to win.

This is no longer a forward-looking case. Kry built France under the Livi brand. Evondos achieved immediate Dutch scale through its combination with Medido. LINK Medical extended its Nordic CRO footprint into Germany and the UK. Medanets entered the UK and Ireland, adapted to local clinical protocols, and converted pilots into repeatable NHS Trust sales. None of these operators simply ported a Nordic operating model wholesale — each adapted execution to local context. The transferable asset is the validated solution; the local delivery model is built deliberately.

For investors, the relevant insight is one of fit. A defined set of Nordic healthcare companies has emerged from a domestic environment that gave them the time and market access to validate solutions to problems EU5 systems are only now confronting.

Vesa Komssi, EVP, Private Sector Consulting at Nordic Healthcare Group

Get in touch with our Strategy & transactions team

Executive Vice President, Private Sector Consulting

Vesa Komssi

+358 50 331 7978
vesa.komssi@nhg.fi

Senior Partner

Eemeli Kuumola

+35850 349 7575
eemeli.kuumola@nhg.fi

Senior Manager, Sweden

Edoardo Angelini-Rota

edoardo.angelini-rota@nhg.se

Director, Finland

Ville Saranen

ville.saranen@nhg.fi